Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas

[1]  R. Paschke,et al.  Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules. , 2014, Thyroid : official journal of the American Thyroid Association.

[2]  R. Paschke,et al.  Inverse correlation of miRNA and cell cycle-associated genes suggests influence of miRNA on benign thyroid nodule tumorigenesis. , 2013, The Journal of clinical endocrinology and metabolism.

[3]  Kuender D Yang,et al.  Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma. , 2013, The Journal of clinical endocrinology and metabolism.

[4]  F. Consorti,et al.  HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells. , 2012, Oncology reports.

[5]  C. Croce,et al.  Let-7a down-regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) gene. , 2012, The Journal of clinical endocrinology and metabolism.

[6]  M. Rugge,et al.  MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome. , 2012, Thyroid : official journal of the American Thyroid Association.

[7]  O. Wang,et al.  Overexpression of miR-221 is associated with aggressive clinicopathologic characteristics and the BRAF mutation in papillary thyroid carcinomas , 2012, Medical Oncology.

[8]  M. Guerrero,et al.  MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer , 2012, Cancer.

[9]  S. Steinberg,et al.  Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples. , 2012, Thyroid : official journal of the American Thyroid Association.

[10]  Olivier Elemento,et al.  A Panel of Four miRNAs Accurately Differentiates Malignant from Benign Indeterminate Thyroid Lesions on Fine Needle Aspiration , 2012, Clinical Cancer Research.

[11]  Ricardo Henao,et al.  Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma. , 2012, Journal of molecular endocrinology.

[12]  Huiling He,et al.  MicroRNA signature in thyroid fine needle aspiration cytology applied to "atypia of undetermined significance" cases. , 2012, Thyroid : official journal of the American Thyroid Association.

[13]  S. Sidhu,et al.  Evolution of the “autophagamiR” , 2011, Autophagy.

[14]  N. Guevara,et al.  Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland? , 2011, Endocrine-related cancer.

[15]  G. Chiappetta,et al.  miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting. , 2011, The Journal of clinical endocrinology and metabolism.

[16]  A. Fusco,et al.  MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1alpha. , 2011, The Journal of clinical endocrinology and metabolism.

[17]  A. Gill,et al.  MicroRNA Profiling of Sporadic and Hereditary Medullary Thyroid Cancer Identifies Predictors of Nodal Metastasis, Prognosis, and Potential Therapeutic Targets , 2011, Clinical Cancer Research.

[18]  M. Nikiforova,et al.  MicroRNA Signature Distinguishes the Degree of Aggressiveness of Papillary Thyroid Carcinoma , 2011, Annals of Surgical Oncology.

[19]  B. Trink,et al.  Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples. , 2011, Thyroid : official journal of the American Thyroid Association.

[20]  K. Jażdżewski,et al.  Thyroid Hormone Receptor β (THRB) Is a Major Target Gene for Micro-RNAs Deregulated in Papillary Thyroid Carcinoma (PTC) , 2011 .

[21]  Subbaya Subramanian,et al.  MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. , 2010, Cancer research.

[22]  Xiaofei Zheng,et al.  miR-183 inhibits TGF-β1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells , 2010, BMC Cancer.

[23]  K. Schmid,et al.  Lack of Correlation between BRAF V600E Mutational Status and the Expression Profile of a Distinct Set of miRNAs in Papillary Thyroid Carcinoma , 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[24]  K. Mimori,et al.  Over- and under-expressed microRNAs in human colorectal cancer. , 2009, International journal of oncology.

[25]  P. Northcott,et al.  MicroRNA-199b-5p Impairs Cancer Stem Cells through Negative Regulation of HES1 in Medulloblastoma , 2009, PloS one.

[26]  Shu Zheng,et al.  MicroRNA‐183 regulates Ezrin expression in lung cancer cells , 2008, FEBS letters.

[27]  S. Schokrpur,et al.  Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells , 2008, Oncogene.

[28]  S. Le,et al.  Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth , 2008, PloS one.

[29]  T. Fahey,et al.  MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma , 2008, Modern Pathology.

[30]  G. Tseng,et al.  MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. , 2008, The Journal of clinical endocrinology and metabolism.

[31]  C. Croce,et al.  Specific microRNAs are downregulated in human thyroid anaplastic carcinomas , 2007, Oncogene.

[32]  Stephen R. Master,et al.  Differential Expression of miRNAs in Papillary Thyroid Carcinoma Compared to Multinodular Goiter Using Formalin Fixed Paraffin Embedded Tissues , 2007, Endocrine pathology.

[33]  C. Eng,et al.  A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. , 2006, The Journal of clinical endocrinology and metabolism.

[34]  Tara L. Naylor,et al.  microRNAs exhibit high frequency genomic alterations in human cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[35]  C. Croce,et al.  MicroRNA deregulation in human thyroid papillary carcinomas. , 2006, Endocrine-related cancer.

[36]  S. Asa,et al.  Pathogenetic mechanisms in thyroid follicular-cell neoplasia , 2006, Nature Reviews Cancer.

[37]  C. Croce,et al.  The role of microRNA genes in papillary thyroid carcinoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Maura Pandolfi,et al.  PTEN and Egr-1 expression in thyroid proliferative lesions. , 2005, Cancer letters.

[39]  N. Eberhardt,et al.  The PAX8/PPARγ fusion oncoprotein transforms immortalized human thyrocytes through a mechanism probably involving wild-type PPARγ inhibition , 2004, Oncogene.

[40]  D. Sheer,et al.  Characterisation of human thyroid epithelial cells immortalised in vitro by simian virus 40 DNA transfection. , 1989, British Journal of Cancer.

[41]  P. Singh,et al.  Tumours of the jaws. , 1956, East African medical journal.

[42]  H. Moch,et al.  MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas. , 2013, The Journal of clinical endocrinology and metabolism.

[43]  O. Kranenburg,et al.  The value of miRNA in diagnosing thyroid cancer: a systematic review. , 2012, Cancer biomarkers : section A of Disease markers.

[44]  N. Eberhardt,et al.  The Putative PAX8/PPARγ Fusion Oncoprotein Exhibits Partial Tumor Suppressor Activity through Up-Regulation of Micro-RNA-122 and Dominant-Negative PPARγ Activity. , 2011, Genes & cancer.

[45]  Hong Wang,et al.  miRNA expression in a human papillary thyroid carcinoma cell line varies with invasiveness. , 2010, Endocrine journal.

[46]  J. Chan,et al.  Thyroid and Parathyroid , 2009 .

[47]  L. Bondeson.  Tumours of the thyroid and parathyroid , 2004 .

[48]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .

[49]  A. Frilling,et al.  Growth regulation of normal thyroids and thyroid tumors in man. , 1990, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.